Show
December 18, 2017 | by Alison Sage, D.O.
What, exactly, is the difference between HDL and LDL cholesterol (which one’s good)? And what are triglycerides? Why should you care about how many white or red blood cells you have circulating? Because your blood can tell you a lot about how healthy you are. There is so much information pumping through your veins. Doctors can see whether you’re diabetic, anemic or fighting an infection. They can gather clues to how well your liver, heart or thyroid is working. Blood
tests are often part of a routine check-up, as doctors analyze how your body is working. Unless you’re a medical professional, however, the results can be hard to decipher.
It’s important to find a physician you feel comfortable with and confident in, who partners with you in your personal health goals. Find the right Healthy Driven doctor for you.
You may be interested inIf you have reached this screen, your current device or browser is unable to access the full Edward-Elmhurst Health Web site. To see the full site, please upgrade your browser to the most recent version of Safari, Chrome, Firefox or Internet Explorer. If you cannot upgrade your browser, you can remain on this site. In a landmark study, scientists at Houston Methodist Research Institute discovered what makes white blood cell counts spike in individuals who have high cholesterol, possibly leading to new therapies for heart disease. Led by Longhou Fang, Ph.D., an associate professor in the Center for Cardiovascular Regeneration, and his postdoctoral fellow Qilin Gu, Ph.D., the team looked at hypercholesterolemia, which is the type of high cholesterol that causes very high levels of LDL -- the so-called "bad" cholesterol -- to circulate in the blood. They identified a new regulatory mechanism in zebrafish models responsible for this increase in white blood cells typically seen in people with these high LDL levels, which are known to increase a person's risk for cardiovascular disease, the leading cause of morbidity and mortality in the U.S. and globally. "Our findings may explain why this can happen," Fang said. "This mechanism we identified activates a protein called SREBP2 that in turn leads to the development of more hematopoietic stem cells (HSPCs), which are the precursors to white blood cells and the process by which all mature blood cells are produced. We were able to show that targeting this protein using its antagonist can reduce the HSPC counts to bring down the white blood cell counts. This insight may lead to a new strategy to treat atherosclerotic cardiovascular disease." Additionally, Fang says finding this new pathway that controls the generation of HSPCs could be useful for treating blood disorders, such as leukemia and anemia, in the future. For instance, he says the plant-derived drug betulin, which is an SREBP2 inhibitor, could possibly be repurposed to mitigate the progression of leukemia. Even further down the line, he said this also holds promise for bone marrow regeneration using patient-derived hematopoietic stem cells, which would eliminate the need to find a donor. Initially reported in an article titled "AIBP-mediated cholesterol efflux instructs hematopoietic stem and progenitor cell fate" in the journal Science, the study has since been cited by the New England Journal of Medicine (NEJM) and Nature Reviews Cardiology. In the NEJM editorial, the authors write, "This study certainly teaches us that cholesterol metabolism and inflammation are interconnected in the bone marrow environment through the transcription factor SREBP2." They go on to say, "The most notable aspect of the study...is the implication of 'cholesterol metabolism' genes in the biologic makeup of HSPCs. These findings provide support for the hypothesis that cholesterol metabolism is a driver of inflammation in cardiovascular disease." Fang and his colleagues say their next steps are to continue exploring the role of cholesterol metabolism in hematopoiesis, saying that their findings bring them one step closer to their ultimate goal of generating patient-oriented HSPCs, which will be essential for the progress of regenerative and precision medicine. Story Source: Materials provided by Houston Methodist. Note: Content may be edited for style and length. Can high cholesterol cause low white blood cell count?Higher Total Cholesterol and LDL-C Levels Associated With Lower WBC Count. There are modest associations between higher lipid levels and circulating leukocyte counts in humans, according to study results published in the Journal of Clinical Lipidology.
Is cholesterol associated with white blood cells?Low levels of HDL (high-density lipoprotein) cholesterol were observationally associated with high peripheral blood leukocytes, neutrophils, lymphocytes, monocytes, eosinophils, and basophils.
What diseases lower your white blood cell count?Advertisement. Aplastic anemia.. Chemotherapy.. HIV/AIDS.. Hypersplenism (an abnormality of the spleen causing blood cell destruction). Kostmann's syndrome (a congenital disorder involving low production of neutrophils). Leukemia.. Lupus.. Malnutrition and vitamin deficiencies.. What happens with a very low white blood count?If the neutrophil count is very low, fewer than 500 neutrophils in a microliter of blood, it is called severe neutropenia. When the neutrophil count gets this low, even the bacteria normally living in a person's mouth, skin, and gut can cause serious infections.
|